Jinhwan Kim is currently working as an assistant professor of biomedical engineering at the University of California Davis, and holds a joint appointment with the Department of Surgery at UC Davis Health. 

Kim’s research centers on the integration of nanotechnology, cell engineering, and bioimaging to augment and optimize cell-based therapies, including immunotherapy and stem cell therapy. His research group, the Laboratory for Cell Nanoengineering, investigates the augmentation of endogenous functional/therapeutic cells (e.g., stem cells, T cells, NK cells) with foreign and biocompatible nanoparticles.

Kim holds a PhD in Chemistry from Pohang University of Science and Technology.